Clinical Microbiology Reviews

Papers
(The median citation count of Clinical Microbiology Reviews is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Extracutaneous sporotrichosis401
2025 Acknowledgment of CMR Reviewers191
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders180
Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values—laboratory and clinical utility140
Vaccines and monoclonal antibodies to prevent healthcare-associated bacterial infections138
The long reach of influenza and other respiratory viruses: from acute epithelial injury to post-viral lung disease137
Erratum for Nyaruaba et al., “Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: a Roadmap for Future Outbreaks”129
Antibiotic tolerance among clinical isolates: mechanisms, detection, prevalence, and significance119
Integrating whole-genome sequencing into antimicrobial resistance surveillance: methodologies, challenges, and perspectives119
Viral infections and pathogenesis of glaucoma: a comprehensive review104
Intestinal biofilms: pathophysiological relevance, host defense, and therapeutic opportunities97
The sex hormone-gut microbiome axis: mechanistic drivers of sex-disparate bacterial infection outcomes and precision clinical interventions94
Emerging hybrid shigatoxigenic and enteropathogenic Escherichia coli serotype O80:H2 in humans and calves92
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant91
HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus89
Progression of antibiotic resistance in Neisseria meningitidis85
Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options84
Decontamination approaches and strategies for the prevention of sink drain-related healthcare-associated infections81
A review of post-exposure strategies for high-consequence viral pathogens in the laboratory81
Canonical fact versus hypothesis testing to decipher transmission of non-tuberculous and tuberculous mycobacteria: a comparative review76
Review of BCG immunotherapy for bladder cancer74
Henipaviruses: epidemiology, ecology, disease, and the development of vaccines and therapeutics71
Non- faecium non- faecalis enterococci: a review of clinical manifestations, virulence factors, and antimicrobial resistance69
Extrapolation and comparison of West Nile virus- and Usutu virus-associated neurological diseases in humans: linking pathology to clinical symptoms69
Clonorchiasis and opisthorchiasis: epidemiology, transmission, clinical features, morbidity, diagnosis, treatment, and control69
Neisseria gonorrhoeae vaccines: a contemporary overview62
Congenital Syphilis: a Review of Global Epidemiology62
Drug-resistant Acinetobacter baumannii : mortality, emerging treatments, and future pharmacological targets for a WHO priority pathogen62
Erratum for Cho et al., “Recent advances in therapeutic probiotics: insights from human trials”59
Bacterial and fungal infections in persons who inject drugs57
Bacillus cereus Invasive Infections in Preterm Neonates: an Up-to-Date Review of the Literature57
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease56
BCG therapy in bladder cancer and its tumor microenvironment interactions53
Rapid and accurate testing for urinary tract infection: new clothes for the emperor52
Diagnosis, Management, and Future Control of Cholera52
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes52
The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections51
Agnostic Sequencing for Detection of Viral Pathogens50
Artemisinin-resistant malaria50
Lyme borreliosis in Brazil: a critical review on the Baggio–Yoshinari syndrome (Brazilian Lyme-like disease)49
Convalescent plasma for COVID-19: planning for the next pandemic using the worldwide experience49
Immunosuppressant imprecision: multidirectional effects on metabolism and microbiome43
Editorial Board42
2021 Acknowledgment of CMR Reviewers42
Harnessing the host response for precision infectious disease diagnosis42
Floods and infectious diseases: public health lessons from the 2024 southern Brazil disaster40
COVID-19 therapeutics38
Pathogenesis of viral infections during pregnancy34
Pneumocystis jirovecii pneumonia in people living with HIV: a review34
The challenges of difficult-to-treat Acinetobacter infections34
The oral penems and carbapenems33
Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing31
An updated list of eumycetoma causative agents and their differences in grain formation and treatment response30
Editorial Board29
Editorial Board28
Invasive fusariosis27
Human toxocariasis26
Updated Review onNocardiaSpecies: 2006–202124
Osteoarticular Mycoses24
Candidate Phyla Radiation, an Underappreciated Division of the Human Microbiome, and Its Impact on Health and Disease24
Clinical Microbiology Reviews : a 21st century vision23
Klebsiella oxytoca Complex: Update on Taxonomy, Antimicrobial Resistance, and Virulence23
Machine Learning for Antimicrobial Resistance Prediction: Current Practice, Limitations, and Clinical Perspective23
Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management22
Schistosomiasis: cercarial finding and recognizing of human hosts as a prerequisite of invasion22
Host Immunity and Immunization Strategies for Clostridioides difficile Infection22
Narrative review on bacteria-derived metabolites in the pathogenesis of ulcerative colitis22
Environmental and physiological factors influencing the survival of resistant Salmonella under infection-related gut conditions21
Skin microbiota in atopic dermatitis: victim or executioner?21
Role of the intestinal microbiota in contributing to weight disorders and associated comorbidities20
The endothelium at the interface between tissues and Staphylococcus aureus in the bloodstream19
Drug-resistant tuberculosis: a priority pathogen for enhanced public health research and practice18
Current perspectives in the epidemiology and control of lymphatic filariasis17
Surveillance and prevention of infection in clinical xenotransplantation16
Masks and respirators for prevention of respiratory infections: a state of the science review15
Correction for Moreland et al., “Rapid and accurate testing for urinary tract infection: new clothes for the emperor”15
Advancements and challenges in antifungal therapeutic development15
A call for the United States to continue investing in science15
The American Society for Microbiology’s evidence-based laboratory medicine practice guidelines for the diagnosis of bloodstream infections using rapid tests: a systematic review and meta-analysis15
Scedosporiosis and lomentosporiosis: modern perspectives on these difficult-to-treat rare mold infections14
2023 Acknowledgment of CMR Reviewers14
Human Listeriosis14
Streptococcus pneumoniae β-lactam resistance: epidemiological trends, molecular drivers, and innovative control strategies in the post-pandemic era14
Optimized use and performance of culture for periprosthetic joint infection diagnosis: a comprehensive literature review14
A narrative review of coagulase-negative staphylococci in diabetic foot infections13
American Society for Microbiology evidence-based laboratory medicine practice guidelines to reduce blood culture contamination rates: a systematic review and meta-analysis13
Fastidious or rarely isolated gram-negative rods with a particular focus on Kingella kingae13
Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies13
2024 Acknowledgment of CMR Reviewers12
Neurological complications caused by SARS-CoV-212
Worldwide Control and Management of Chagas Disease in a New Era of Globalization: a Close Look at Congenital Trypanosoma cruzi Infection12
Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear Cells12
Adoptive T-cell therapy for virus-associated diseases11
The potential for development of clinically relevant microbial resistance to rifaximin-α: a narrative review11
Monkeypox Virus Infections in Humans11
Genital cutaneous candidiasis versus chronic recurrent vulvovaginal candidiasis: distinct diseases, different populations11
Recent advances in the influenza virus vaccine landscape: a comprehensive overview of technologies and trials11
0.041826963424683